← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Integral Molecular
Philadelphia, PA
$65,872,961
Total funding
53
Grants
Funding over time
peak $7.1M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$65,872,961 · 53
By mechanism
N01$28,897,888 · 4
R44$18,406,419 · 12
R43$7,968,096 · 25
R42$2,657,177 · 1
SB1$1,846,470 · 1
N44$1,500,000 · 1
Investigators at Integral Molecular
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Discovery and Characterization of B-Cell Epitopes for Hepatitis C Virus and Ebola Virus$5,498,687
N01 · FY2015 · AI
B Cell Epitope Discovery: Dengue, Hepatitis C, Ebola, and Chikungunya viruses$2,278,773
N01 · FY2009 · AI
B-CELL EPITOPE DISCOVERY AND MECHANISMS OF ANTIBODY PROTECTION$2,000,000
N01 · FY2020 · AI
B Cell Epitope Discovery: Dengue, Hepatitis C, Ebola, and Chikungunya viruses$1,823,674
N01 · FY2011 · AI
B Cell Epitope Discovery: Dengue, Hepatitis C, Ebola, and Chikungunya viruses$1,742,333
N01 · FY2010 · AI
B cell Epitope Discovery and Mechanisms of Antibody Protection for Enterovirus and Bunyavirus Entry Proteins$1,722,325
N01 · FY2025 · AI
B Cell Epitope Discovery: Dengue, Hepatitis C, Ebola, and Chikungunya viruses$1,650,200
N01 · FY2013 · AI
B Cell Epitope Discovery: Dengue, Hepatitis C, Ebola, and Chikungunya viruses$1,601,718
N01 · FY2012 · AI
B cell Epitope Discovery and Mechanisms of Antibody Protection for Enterovirus and Bunyavirus Entry Proteins$1,569,483
N01 · FY2024 · AI
ANTIBODY REAGENTS FOR IMMUNOLOGIC ANALYSIS OF UNDER-REPRESENTED MAMMALIAN MODELS$1,500,000
N44 · FY2025 · AI
Discovery and Characterization of B-Cell Epitopes for Hepatitis C Virus and Ebola Virus$1,433,096
N01 · FY2014 · AI
B-Cell Epitope Discovery and Mechanisms of Antibody Protection for ZIKV, MARV, and VEEV Envelope Proteins$1,363,256
N01 · FY2019 · AI
B-Cell Epitope Discovery and Mechanisms of Antibody Protection for ZIKV, MARV, VEEV Envelope Proteins$1,060,517
N01 · FY2023 · AI
B-Cell Epitope Discovery and Mechanisms of Antibody Protection for ZIKV, MARV, VEEV Envelope Proteins$1,044,551
N01 · FY2022 · AI
B-CELL EPITOPE DISCOVERY AND MECHANISMS OF ANTIBODY PROTECTION$1,028,905
N01 · FY2021 · AI
B-Cell Epitope Discovery and Mechanisms of Antibody Protection for ZIKV, MARV, VEEV Envelope Proteins$1,013,565
N01 · FY2020 · AI
Next Generation Specificity Screening for Biotherapeutics using an Extracellular Proteome Array$934,299
R44 · FY2020 · GM
Specificity Screening Drug Development Tool for Biotherapeutic Safety$929,016
SB1 · FY2025 · GM
High-throughput Discovery of Antibodies against Understudied Membrane Proteins using mRNA$923,143
R44 · FY2025 · GM
Specificity Screening Drug Development Tool for Biotherapeutic Safety$917,454
SB1 · FY2024 · GM